
MAIA Biotechnology
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,178 | -7,569 | -6,369 | -3,628 |
EBIT | -7,714 | -8,110 | -6,736 | -24,250,191 |
Net Income | -7,178 | -7,943 | -6,369 | -3,628 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,311 | -6,750 | -5,311 | -7,020 |
Cash | 21,338 | 27,595 | 34,413 | 8,658 |
Basic Shares | 60,864 | 60,794 | 32,115 | 32,115 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -22,396 | -23,254 | -19,766 | -15,762 |
EBIT | -22,396 | -23,254 | -20,182 | -16,176 |
Net Income | -22,396 | -23,254 | -19,772 | -15,769 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,844 | -15,704 | -13,071 | -12,096 |
Cash | 8,658,031 | 9,601 | 7,150 | 10,950 |
Basic Shares | 32,115 | 22,197 | 13,262 | 9,277 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.12 |
2026-06-30 | -$0.13 |
2026-03-31 | -$0.14 |
2025-12-31 | -$0.13 |